Public Sector Pension Investment Board Lowers Position in CME Group Inc. (NASDAQ:CME)

Public Sector Pension Investment Board lessened its stake in CME Group Inc. (NASDAQ:CMEGet Rating) by 27.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,972 shares of the financial services provider’s stock after selling 15,859 shares during the period. Public Sector Pension Investment Board’s holdings in CME Group were worth $8,387,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. MUFG Americas Holdings Corp boosted its position in CME Group by 3.8% in the 1st quarter. MUFG Americas Holdings Corp now owns 16,886 shares of the financial services provider’s stock worth $4,017,000 after purchasing an additional 611 shares in the last quarter. Capital International Sarl raised its stake in shares of CME Group by 14.9% during the 1st quarter. Capital International Sarl now owns 126,176 shares of the financial services provider’s stock worth $30,012,000 after buying an additional 16,316 shares during the period. Cambridge Investment Research Advisors Inc. raised its stake in shares of CME Group by 5.3% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 37,169 shares of the financial services provider’s stock worth $7,608,000 after buying an additional 1,879 shares during the period. IndexIQ Advisors LLC acquired a new position in shares of CME Group during the 1st quarter worth approximately $27,000. Finally, Curi Wealth Management LLC raised its stake in shares of CME Group by 47.5% during the 1st quarter. Curi Wealth Management LLC now owns 1,142 shares of the financial services provider’s stock worth $271,000 after buying an additional 368 shares during the period. Hedge funds and other institutional investors own 85.56% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. UBS Group reduced their target price on CME Group from $246.00 to $240.00 and set a “buy” rating for the company in a research note on Tuesday, August 2nd. Rosenblatt Securities reduced their target price on CME Group from $171.00 to $161.00 and set a “sell” rating for the company in a research note on Wednesday, October 5th. Credit Suisse Group reduced their target price on CME Group from $216.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, September 6th. Deutsche Bank Aktiengesellschaft upped their target price on CME Group from $200.00 to $202.00 in a research note on Thursday, October 27th. Finally, StockNews.com assumed coverage on CME Group in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $223.86.

CME Group Stock Up 1.0 %

Shares of CME opened at $176.00 on Thursday. CME Group Inc. has a 52-week low of $166.58 and a 52-week high of $256.94. The company has a market capitalization of $63.31 billion, a PE ratio of 23.95, a price-to-earnings-growth ratio of 2.81 and a beta of 0.41. The stock has a fifty day simple moving average of $176.11 and a two-hundred day simple moving average of $192.02. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CMEGet Rating) last issued its earnings results on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.05. CME Group had a return on equity of 10.06% and a net margin of 54.01%. The business had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.23 billion. As a group, equities analysts forecast that CME Group Inc. will post 7.96 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Friday, December 9th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Thursday, December 8th. CME Group’s dividend payout ratio (DPR) is presently 54.42%.

Insiders Place Their Bets

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the firm’s stock in a transaction on Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total value of $98,195.00. Following the completion of the sale, the director now directly owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Daniel R. Glickman sold 500 shares of the stock in a transaction on Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total transaction of $98,195.00. Following the completion of the transaction, the director now directly owns 14,597 shares in the company, valued at approximately $2,866,704.83. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard purchased 48,645 shares of the stock in a transaction dated Friday, November 4th. The shares were acquired at an average price of $170.00 per share, with a total value of $8,269,650.00. Following the completion of the acquisition, the director now owns 247,843 shares in the company, valued at approximately $42,133,310. The disclosure for this purchase can be found here. Insiders sold 5,610 shares of company stock valued at $1,123,970 in the last three months. 0.30% of the stock is currently owned by insiders.

About CME Group

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEGet Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.